{
    "id": 24085,
    "fullName": "CD79B Y196H",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "CD79B Y196H lies within the ITAM motif of the Cd79b protein (PMID: 20054396). Y196H confers a gain of function to the Cd79b protein as demonstrated by increased Bcr signaling due to inhibition of Lyn (PMID: 20054396).",
            "references": [
                {
                    "id": 6268,
                    "pubMedId": 20054396,
                    "title": "Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20054396"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 974,
        "geneSymbol": "CD79B",
        "terms": [
            "CD79B",
            "AGM6",
            "B29",
            "IGB"
        ]
    },
    "variant": "Y196H",
    "createDate": "07/08/2016",
    "updateDate": "07/08/2016",
    "referenceTranscriptCoordinates": {
        "id": 108775,
        "transcript": "NM_000626",
        "gDna": "chr17:g.63929439A>G",
        "cDna": "c.586T>C",
        "protein": "p.Y196H",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 7271,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, diffuse large B-cell lymphoma cells harboring CD79B Y196F demonstrated sensitivity to treatment with Sotrastaurin (AEB071) in culture and in vivo, resulting in down regulation of NF-kB signaling, cell death, and inhibition of tumor growth (PMID: 21324920).",
            "molecularProfile": {
                "id": 24815,
                "profileName": "CD79B Y196H"
            },
            "therapy": {
                "id": 621,
                "therapyName": "AEB071",
                "synonyms": null
            },
            "indication": {
                "id": 50745,
                "name": "diffuse large B-cell lymphoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3976,
                    "pubMedId": 21324920,
                    "title": "Protein kinase C inhibitor sotrastaurin selectively inhibits the growth of CD79 mutant diffuse large B-cell lymphomas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21324920"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 12107,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, a patient with primary central nervous system lymphoma harboring both CD79B Y196H and MYD88 L265P demonstrated a partial response when treated with Imbruvica (ibrutinib) (PMID: 28619981).",
            "molecularProfile": {
                "id": 28411,
                "profileName": "CD79B Y196H MYD88 L265P"
            },
            "therapy": {
                "id": 768,
                "therapyName": "Ibrutinib",
                "synonyms": null
            },
            "indication": {
                "id": 3234,
                "name": "central nervous system lymphoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 10035,
                    "pubMedId": 28619981,
                    "title": "Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28619981"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 24815,
            "profileName": "CD79B Y196H",
            "profileTreatmentApproaches": [
                {
                    "id": 10015,
                    "name": "PKC Inhibitor (Pan)",
                    "profileName": "CD79B Y196H"
                }
            ]
        },
        {
            "id": 28411,
            "profileName": "CD79B Y196H MYD88 L265P",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 108775,
            "transcript": "NM_000626",
            "gDna": "chr17:g.63929439A>G",
            "cDna": "c.586T>C",
            "protein": "p.Y196H",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}